<DOC>
	<DOCNO>NCT00593723</DOCNO>
	<brief_summary>Concurrent chemotherapy radiation therapy standard care inoperable patient esophagus cancer . Unfortunately , 5-year survival 20 % population quite low . Methods intensify radiation therapy delivery without increase local toxicity need . Intensity modulate radiation therapy ( IMRT ) advance method deliver external beam radiation may minimize volume normal tissue irradiate high dose thus decrease risk normal tissue toxicity . The propose study prospectively test whether IMRT tolerable deliver IMRT dose 60 Gy patient esophagus cancer .</brief_summary>
	<brief_title>IMRT Tomotherapy Esophagus Cancer</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Age &gt; = 18 Karnofsky Performance Status &gt; = 60 TNM Stages T14 , N03 , M0 Pathologic confirmation esophagus cancer Evaluation medical oncologist determines patient medically fit concurrent chemotherapy Evaluation surgeon determines patient unresectable Age &lt; 18 Karnofsky Performance Status &lt; 60 Radiographic pathologic evidence distant metastatic disease ( classified M1b AJCC stag manual ) Prior radiation therapy thorax upper abdomen , prevent definitive radiation therapy . Pregnant lactating , female .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>IMRT</keyword>
</DOC>